BACKGROUND AND PURPOSE: As potential therapies aimed at halting or slowing the decline in upper motor neuron function in patients with amyotrophic lateral sclerosis (ALS) or primary lateral sclerosis (PLS) are developed, a quantitative method for monitoring response will be necessary. Measurement of fractional anisotropy (FA) using diffusion tensor imaging (DTI) over time should parallel functional decline from upper motor neuron degeneration in these patients. PATIENTS AND METHODS: Two patients with definite ALS were imaged at 3.0 T and FA values were obtained in the corticospinal tract every 3 months for 1 year. The FA values were compared to normal age-matched controls. RESULTS: Both patients showed linear decreases in FA values over time with R(2) values ranging from 0.93 to 0.99. The decline became statistically significant over the course of the study. Qualitative decreases in anisotropy were also evident on FA maps. CONCLUSION: If these trends can be validated in greater numbers of patients, DTI may serve as an objective quantitative biomarker for disease progression in patients with upper motor neuron disease.
BACKGROUND AND PURPOSE: As potential therapies aimed at halting or slowing the decline in upper motor neuron function in patients with amyotrophic lateral sclerosis (ALS) or primary lateral sclerosis (PLS) are developed, a quantitative method for monitoring response will be necessary. Measurement of fractional anisotropy (FA) using diffusion tensor imaging (DTI) over time should parallel functional decline from upper motor neuron degeneration in these patients. PATIENTS AND METHODS: Two patients with definite ALS were imaged at 3.0 T and FA values were obtained in the corticospinal tract every 3 months for 1 year. The FA values were compared to normal age-matched controls. RESULTS: Both patients showed linear decreases in FA values over time with R(2) values ranging from 0.93 to 0.99. The decline became statistically significant over the course of the study. Qualitative decreases in anisotropy were also evident on FA maps. CONCLUSION: If these trends can be validated in greater numbers of patients, DTI may serve as an objective quantitative biomarker for disease progression in patients with upper motor neuron disease.
Authors: J J Neil; S I Shiran; R C McKinstry; G L Schefft; A Z Snyder; C R Almli; E Akbudak; J A Aronovitz; J P Miller; B C Lee; T E Conturo Journal: Radiology Date: 1998-10 Impact factor: 11.105
Authors: Camilla R V Blain; Victoria C Williams; Clare Johnston; Biba R Stanton; Jeban Ganesalingam; Jozef M Jarosz; Derek K Jones; Gareth J Barker; Steve C R Williams; Nigel P Leigh; Andy Simmons Journal: Amyotroph Lateral Scler Date: 2007-10-08
Authors: Aziz M Uluğ; Thomas Grünewald; Michael T Lin; Ayeesha K Kamal; Christopher G Filippi; Robert D Zimmerman; M Flint Beal Journal: J Magn Reson Imaging Date: 2004-01 Impact factor: 4.813
Authors: Yu Zhang; Norbert Schuff; Susan C Woolley; Gloria C Chiang; Lauren Boreta; Joel Laxamana; Jonathan S Katz; Michael W Weiner Journal: Amyotroph Lateral Scler Date: 2011-07-11
Authors: Nobue K Iwata; Justin Y Kwan; Laura E Danielian; John A Butman; Fernanda Tovar-Moll; Elham Bayat; Mary Kay Floeter Journal: Brain Date: 2011-07-28 Impact factor: 13.501
Authors: Alexander W Thomas; Richard Watts; Christopher G Filippi; Joshua P Nickerson; Trevor Andrews; Gregory Lieberman; Magdalena R Naylor; Margaret J Eppstein; Kalev Freeman Journal: PLoS One Date: 2017-06-12 Impact factor: 3.240
Authors: Miguel Mazón; Juan Francisco Vázquez Costa; Amadeo Ten-Esteve; Luis Martí-Bonmatí Journal: Front Neurosci Date: 2018-10-25 Impact factor: 4.677
Authors: Kumar Abhinav; Fang-Cheng Yeh; Ahmed El-Dokla; Lisa M Ferrando; Yue-Fang Chang; David Lacomis; Robert M Friedlander; Juan C Fernandez-Miranda Journal: Front Hum Neurosci Date: 2014-04-29 Impact factor: 3.169
Authors: G Grolez; C Moreau; V Danel-Brunaud; C Delmaire; R Lopes; P F Pradat; M M El Mendili; L Defebvre; D Devos Journal: BMC Neurol Date: 2016-08-27 Impact factor: 2.474
Authors: Ashwag R Alruwaili; Kerstin Pannek; Robert D Henderson; Marcus Gray; Nyoman D Kurniawan; Pamela A McCombe Journal: BMC Med Imaging Date: 2020-08-03 Impact factor: 1.930